SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $88,100,083 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Surrozen, Inc. | Unresolved | COM | $49,744,853 | 1,916,950 |
| ORIC Pharmaceuticals Inc. | ORIC | COM | $38,346,615 | 3,540,777 |
| Revolution Medicines Inc | RVMD | COM | $8,615 | 46 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.